If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCyanconnode Regulatory News (CYAN)

Share Price Information for Cyanconnode (CYAN)

Share Price is delayed by 15 minutes
Get Live Data
8.05    0.00 (0.00%)
Bid:
7.90
Ask:
8.20
Spread: 0.30 (3.797%)
Market Cap: £28.34m
CYAN Live PriceLast checked at - London Stock Exchange

Intraday Cyanconnode Share Chart

Form 8 (Opening Position Disclosure) - Replacement

5 Mar 2026 16:17

RNS Number : 5614V
CyanConnode Holdings PLC
05 March 2026
Β 

Replacement: This announcement replaces the "CyanConnode Holdings plc - Form 8 (OPD)" announcement released at 12:52:13 on 17 February 2026 with RNS Number 3736T. The interests disclosed in respect of Peter Tyler, his close relatives and related trusts have been amended. All other information, save for the date of disclosure, remains unchanged.

Β 

FORM 8 (OPD)

Β 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

CyanConnode Holdings plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

CyanConnode Holdings plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

16 February 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

Β 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Β 

Class of relevant security:

Β 

Ordinary shares of 2 pence each

("Ordinary Shares")

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

Β 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

Β 

TOTAL:

Nil

Nil

Nil

Nil

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

(b) Rights to subscribe for new securities

Β 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

Β 

Β 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Directors' interests

a) Ordinary Shares held by the directors of CyanConnode Holdings plc, their close relatives and related trusts:

Director

Number of Ordinary Shares held

Percentage of total issued ordinary share capital

Peter Tyler and associated persons

21,199,227*

5.90

William David Johns-Powell

19,621,561

5.47

John Cronin

13,062,451**

3.64

Heather Peacock

2,822,966***

0.79

Bjorn Lindblom

912,377

0.25

Lyndon Faulkner

500,000

0.14

Notes:

* - includes 723,794 ordinary shares held by his daughter, Jessica Pullen; 4,407,556 shares held personally by his brother, Barrie Tyler, together with 13,224,837 shares held by Nathan Tyler and Simon Tyler (sons of Barrie Tyler) and their close relatives (excluding Barrie Tyler), who also hold 2,217,700 cash-settled derivatives; and 236,389 shares held by his brother Andrew Tyler, together with Andrew's wife, Sharon Tyler

** - includes 5,672,359 shares held jointly with the CyanConnode Holdings plc Employee Benefit Trust ("EBT") pursuant to a Joint Share Ownership Plan ("JSOP")

*** - includes 1,331,498 shares held jointly with the EBT pursuant to a JSOP

Β 

b) Ordinary Shares held by entities connected with the directors of CyanConnode Holding plc

Β 

Number of Ordinary Shares held

Percentage of total issued ordinary share capital

Albert E Sharp LLP *

2,279,241

0.63

Notes:

* - Albert E Sharp LLP is a firm in which Peter Tyler's brother, Barrie Tyler, is a partner, and exercises discretion over 2,279,241 of the 6,219,180shares held by the firm under discretion.

Β 

c) Options or awards granted under the share plans of CyanConnode Holdings plc held by the directors of CyanConnode Holdings plc, their close relatives and related trusts:

Β 

Name

Name of Share Option Scheme

Number of Options

Exercise Price

(Β£)

Grant Date

Vesting Date

Expiry Date

Vesting Status

William David Johns-Powell

Unapproved

250,000

0.1000

28/09/20

28/09/24

28/09/30

Vested

Heather Peacock

Unapproved

25,000

0.4000

11/12/17

11/12/21

11/12/27

Vested

Unapproved

90,909

0.1000

22/09/20

22/09/24

22/09/30

Vested

Unapproved

100,000

0.1575

17/11/23

17/11/23

17/11/33

Vested

Unapproved

100,000

0.1575

17/11/23

31/03/24

17/11/33

Vested

Unapproved

100,000

0.1575

17/11/23

31/03/25

17/11/33

Vested

Unapproved

68,021

0.1400

17/11/23

17/11/23

17/11/33

Vested

Unapproved

68,021

0.1400

17/11/23

31/03/24

17/11/33

Vested

Unapproved

68,023

0.1400

17/11/23

31/03/25

17/11/33

Vested

Unapproved

59,525

0.1700

17/11/23

31/01/24

17/11/33

Vested

Unapproved

59,525

0.1700

17/11/23

31/01/25

17/11/33

Vested

Unapproved

59,527

0.1700

17/11/23

31/01/26

17/11/33

Vested

EMI

266,291

0.1450

10/11/21

30/06/21

10/11/31

Vested

EMI

266,291

0.1450

10/11/21

30/06/22

10/11/31

Vested

EMI

266,293

0.1450

10/11/21

30/06/23

10/11/31

Vested

EMI

206,474

0.1450

10/11/21

30/06/21

10/11/31

Vested

EMI

206,474

0.1450

10/11/21

30/06/22

10/11/31

Vested

EMI

206,476

0.1450

10/11/21

30/06/23

10/11/31

Vested

John Cronin

EMI

200,000

0.2960

25/01/18

25/01/22

25/01/28

Vested

EMI

360,342

0.1000

22/09/20

22/09/24

22/09/30

Vested

Unapproved

200,000

0.1575

17/11/23

17/11/23

17/11/33

Vested

Unapproved

200,000

0.1575

17/11/23

31/03/24

17/11/33

Vested

Unapproved

200,000

0.1575

17/11/23

31/03/25

17/11/33

Vested

Unapproved

168,694

0.1400

17/11/23

17/11/23

17/11/33

Vested

Unapproved

168,694

0.1400

17/11/23

31/03/24

17/11/33

Vested

Unapproved

168,694

0.1400

17/11/23

31/03/25

17/11/33

Vested

Unapproved

147,619

0.1700

17/11/23

31/01/24

17/11/33

Vested

Unapproved

147,619

0.1700

17/11/23

31/01/25

17/11/33

Vested

Unapproved

147,619

0.1700

17/11/23

31/01/26

17/11/33

Vested

EMI

196,345

0.1450

10/11/21

30/06/21

10/11/31

Vested

EMI

196,345

0.1450

10/11/21

30/06/22

10/11/31

Vested

EMI

196,347

0.1450

10/11/21

30/06/23

10/11/31

Vested

EMI

186,034

0.1450

10/11/21

30/06/21

10/11/31

Vested

EMI

186,034

0.1450

10/11/21

30/06/22

10/11/31

Vested

EMI

186,034

0.1450

10/11/21

30/06/23

10/11/31

Vested

Unapproved

315,689

0.0950

10/10/24

10/10/28

10/10/34

Unvested*

Lyndon Faulkner

EMI

474,833

0.1053

11/11/24

01/11/25

11/11/34

Unvested

EMI

474,833

0.1053

11/11/24

01/11/26

11/11/34

Unvested

EMI

474,833

0.1053

11/11/24

01/11/27

11/11/34

Unvested

EMI

474,836

0.1053

11/11/24

01/11/28

11/11/34

Unvested*

EMI

500,000

0.0994

20/11/24

20/11/28

20/11/34

Unvested*

Peter Tyler

Unapproved

40,000

0.1000

22/09/20

22/09/24

22/09/30

Vested

Β 

Β 

Notes:

* - these unvested options include provisions accelerating vesting on a change of control.

Β 

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(c) Attachments

Β 

Are any Supplemental Forms attached?

Β 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

Β 

Β 

Date of disclosure:

5 March 2026

Contact name:

Heather Peacock, Chief Financial Officer

Telephone number:

+44 (0)1223 865 750

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FEEJAMFTMTBMBTF
Date   Source Headline
15th Sep 20177:00 amRNSHalf-year Report
7th Sep 20177:00 amRNSAppointment of Managing Director India
6th Sep 20177:00 amRNSHolding(s) in Company
31st Aug 20174:36 pmRNSTotal Voting Rights
15th Aug 20177:00 amRNSNew $10M Purchase Order Extension in Bangladesh
31st Jul 201712:30 pmRNSTotal Voting Rights
13th Jul 20178:44 amRNSBoard Realignment and Issue of Options
13th Jul 20177:00 amRNSTrading Update
11th Jul 20172:55 pmRNSBlock listing Update
6th Jul 20177:00 amRNS$1.1 million purchase order from India
3rd Jul 20171:30 pmRNSHolding(s) in Company
30th Jun 20179:18 amRNSTotal Voting Rights
27th Jun 20177:00 amRNSDirector Shareholding and Issue of Options
23rd Jun 20177:00 amRNSDirector Shareholding and Issue of Options
22nd Jun 201710:51 amRNSDirector Shareholding and Issue of Options
19th Jun 20177:00 amRNSFollow-on orders for 10,400 smart meters in India
15th Jun 201712:13 pmRNSResult of AGM
15th Jun 20177:00 amRNSContract Award Extension
19th May 20177:00 amRNSChange of Adviser
16th May 20177:00 amRNSFinal Results
2nd May 20177:00 amRNSTotal Voting Rights
12th Apr 20177:00 amRNSContract Win
10th Apr 20174:50 pmRNSHolding(s) in Company
10th Apr 20174:31 pmRNSHolding(s) in Company
10th Apr 20177:00 amRNSHolding(s) in Company
6th Apr 20179:21 amRNSIssue of Options
6th Apr 20177:00 amRNSDirector Shareholding and Issue of Options
4th Apr 20177:00 amRNSCompletion of Placing and Subscription
3rd Apr 201711:17 amRNSResults of General Meeting
3rd Apr 20177:00 amRNSBoard Changes
17th Mar 201710:36 amRNSResult of Placing and Subscription
17th Mar 20179:00 amRNSProposed £3.2 million fundraise
28th Feb 20177:00 amRNSCyanConnode signs MoU with Tech Mahindra
17th Feb 20173:45 pmRNSDirector/PDMR Shareholding
9th Feb 20177:00 amRNSNew $5.4 million Purchase Order in Bangladesh
6th Feb 20177:00 amRNSContract Win
31st Jan 20175:00 pmRNSTotal Voting Rights
19th Jan 20177:00 amRNSTrading Update
13th Jan 20177:00 amRNSBlock listing Update
30th Dec 20169:00 amRNSDirector Shareholdings
15th Dec 201610:23 amRNSHolding(s) in Company
8th Dec 20167:00 amRNSContract Wins
5th Dec 20167:00 amRNSThird Smart Metering Order with Larsen & Toubro
1st Dec 201611:20 amRNSHolding(s) in Company
1st Dec 201611:09 amRNSDirector Shareholdings
17th Nov 201610:30 amRNSChange of Company Name and Registered Address
15th Nov 20167:00 amRNSCyanConnode Wins Two Frost & Sullivan Awards
9th Nov 20167:00 amRNSIssue of Equity
1st Nov 20168:57 amRNSDirector Shareholdings
7th Oct 20164:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.